179 related articles for article (PubMed ID: 35190778)
41. Ovarian hilus-cell hyperplasia and high serum testosterone in a patient with postmenopausal virilization.
Delibasi T; Erdogan MF; Serinsöz E; Kaygusuz G; Erdogan G; Sertçelik A
Endocr Pract; 2007 Sep; 13(5):472-5. PubMed ID: 17872348
[TBL] [Abstract][Full Text] [Related]
42. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
43. Ovarian Steroid Cell Tumor Masquerading as Steroid-Unresponsive Congenital Adrenal Hyperplasia.
Driano JE; Creo AL; Kumar S; Chattha AJ; Lteif AN
AACE Clin Case Rep; 2021; 7(4):261-263. PubMed ID: 34307849
[TBL] [Abstract][Full Text] [Related]
44. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
45. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
[TBL] [Abstract][Full Text] [Related]
46. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
Johnson JE; Hussain M; Rathore A; Wolfe K
Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
[TBL] [Abstract][Full Text] [Related]
47. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
48. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
49. Use of Successive Pharmacologic Hormone Suppression Testing for a Severe Presentation of Adolescent Polycystic Ovarian Syndrome: A Case Report.
Ravi SJ; Cree-Green M
J Investig Med High Impact Case Rep; 2019; 7():2324709619850215. PubMed ID: 31113263
[TBL] [Abstract][Full Text] [Related]
50. Androgenetic alopecia in a postmenopausal woman as a result of ovarian hyperthecosis.
Kim Y; Marjoniemi VM; Diamond T; Lim A; Davis G; Murrell D
Australas J Dermatol; 2003 Feb; 44(1):62-6. PubMed ID: 12581085
[TBL] [Abstract][Full Text] [Related]
51. Virilizing ovarian steroid cell tumor in a 40 year old South Indian female: a case report.
Salim S; Shantha GP; Patel AD; Kumar AA; Ganeshram P; Mehra N; Rajan AG; Joseph T; Sudhakar L
Cases J; 2009 May; 2():7521. PubMed ID: 19829991
[TBL] [Abstract][Full Text] [Related]
52. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
[TBL] [Abstract][Full Text] [Related]
53. Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer.
J Orrego J; A Chorny J
Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33434176
[TBL] [Abstract][Full Text] [Related]
54. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
[TBL] [Abstract][Full Text] [Related]
55. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
56. Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.
Sanz OA; Martinez PR; Guarch RT; Goñi MJ; Alcazar JL
Maturitas; 2007 Jun; 57(2):214-6. PubMed ID: 17289310
[TBL] [Abstract][Full Text] [Related]
57. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman.
Ozgun MT; Batukan C; Turkyilmaz C; Dolanbay M; Mavili E
Maturitas; 2008 Nov; 61(3):278-80. PubMed ID: 18930614
[TBL] [Abstract][Full Text] [Related]
58. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
59. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman.
Souto SB; Baptista PV; Barreto F; Sousa PF; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2012 Dec; 56(9):672-6. PubMed ID: 23329192
[TBL] [Abstract][Full Text] [Related]
60. A case of hirsutism due to bilateral diffuse ovarian Leydig cell hyperplasia in a post-menopausal woman.
Ali FS; Stanaway SE; Zakhour HD; Spearing G; Bowen-Jones D
Eur J Intern Med; 2003 Nov; 14(7):432-433. PubMed ID: 14614976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
